Axtria is a Gold Sponsor at ISPOR 2023

It is increasingly important for the life sciences industry to adopt an integrated approach to planning, generating, and managing the evidence required for the value of its innovations. Axtria RWE & HEOR’s integrated approach encompasses data infrastructure, data analytics and talents, processes, and governance for agile and actionable insight deliveries. Axtria RWE & HEOR offers integrated evidence generation by leveraging a full spectrum of analytics (descriptive, diagnostic, predictive, and counterfactual) across the product lifecycle, encompassing pre-launch, launch, and post-launch. Our innovative solutions bridge the evidence gap between clinical trials and real-world practice.

We are thrilled to announce Axtria’s participation at ISPOR US 2023 as a Gold Sponsor. Don’t miss our thought-leading workshop, poster presentations, and opportunity to meet our RWE & HEOR experts at the event.

Axtria's Participation

Note:  All times are in Eastern Time

Does Geography Affect Health? 
Insights Derived From Integration of Geography-Based Social Determinants
of Health With Patient-Level Real-World Data

May 10, 2023
10:00 AM-11:00 AM

Facilitated by:

Ron

Ron Preblick

Head US HEOR General Medicines at Sanofi

Keran Moll_New

Keran Moll

Director, HEOR at Regeneron

Won Chen Lee

Won Chan Lee, Ph.D.

Principal, RWE & HEOR, Axtria

Jennifer Ken Opurum

Jennifer Ken-Opurum, Ph.D.

Associate Director, RWE & HEOR, Axtria

Meet Our Leaders at ISPOR 2023

Won Chen Lee

Won Chan Lee, Ph.D.
Principal, RWE & HEOR Practice – Scientific and Strategic Oversight

Dr. Lee serves as RWE & HEOR Practice Lead and Principal at Axtria. He has more than 20 years of experience in HEOR, including strategic planning, economic modeling, RWE database studies, post-marketing studies, HRQL/PRO assessments, HEOR roadmap, value proposition development, HTA assessment, and publication strategies. Dr. Lee holds a Ph.D. in Health Economics from the Graduate Center of the City University, New York, and a master's degree in economics from the University of Grenoble, France.

Chet Badoor

Chet Baboor
Principal, RWE & HEOR  Practice - Client Partner

Chet serves as a Principal and client partner at Axtria’s RWE and HEOR practice leading strategy and operations.  He has more than 20 years of consulting experience in market access and commercialization for life sciences clients. Chet’s particular experience and expertise is to combine and integrate various aspect of go-to-market strategies, RWE & HEOR, technology solutions related to real world data and analytics, commercial analytics and omnichannel marketing. Chet holds a bachelor’s degree in mechanical engineering and an MBA with honors from Thunderbird.

Mihail

Mihail Samnaliev, Ph.D.
Director, RWE & HEOR - Client Engagement Lead

With 18 years of experience in academia and the life sciences industry, Dr. Samnaliev oversees all RWE related scientific studies.  He has deep expertise in study design, economic evaluation, applied statistics, and scientific writing. Previously he worked as a health economist at Boston Children’s Hospital and held a faculty appointment at Harvard Medical School. Dr. Samnaliev has > 50 peer reviewed publications across a range of therapeutic areas, including mental health, cardiovascular, endocrine, respiratory, and neurology.

Jennifer Ken Opurum

Jennifer Ken-Opurum, Ph.D.
Associate Director, RWE & HEOR – Client Engagement Lead

Dr. Ken-Opurum is an experienced consultant, providing solutions to key business problems for clients in the pharma and biotech domain. She has conducted investigative research across therapeutic areas via secondary database analyses, economic modeling, primary surveys, chart reviews, prospective cohort studies, HRQoL/PRO, and publications. She is responsible for study design, project implementation, quality deliverables, and leading teams of RWE & HEOR researchers. Dr. Ken-Opurum holds a Ph.D. in Nutrition Science from Purdue University, Indiana.

Luke

Luke Schmerold
Associate Director, RWE & HEOR – Client Engagement Lead

Luke Schmerold has nine years of experience in HEOR, including RWE studies, economic modeling, and manuscript development. At Axtria, he leads projects and is responsible for providing strategic insights for study design, project implementation, and quality of deliverables. Luke has a bachelor of science degree in Mathematics and Economics from the University of Chicago.

Ruihong Wang

Ruihong Wang
Associate, RWE & HEOR - Data Analytics and Communication

Ruihong Wang is an experienced RWE & HEOR analyst, proficient in medical writing, client communication, and project management. She is an expert programmer in a variety of languages including Python and R. Ruihong has a master’s degree in Business Analytics and Risk Management from Johns Hopkins University.

Poster Presentations

Real-World Evidence Usage in Regulatory Approvals from USFDA and EMA

Authors: Javed Shaikh, Mihail Samnaliev
Presenter: Mihail Samnaliev
Date: Monday, May 8, 2023
Poster session time: 9:45 AM - 1:15 PM
Presentation time: 12:15 PM - 1:15 PM

 

The Potential of Real-World Evidence to Complement Basket Trials for Tissue Agnostic Drugs Targeting Neurotrophic Tropomyosin-Related Kinase Gene Fusions

Authors: Divya Jain, Kadija Diawara, Divya Tamminina, Abdul Shakira, Navneet Ranjan, Geetika Sharma, Javed Shaikh, Mihail Samnaliev
Presenter: Luke Schmerold
Date: Monday, May 8, 2023
Poster session time: 3:15 PM - 6:45 PM
Presentation time: 5:45 PM - 6:45 PM

 

Clinical Benefits of Treating Type 2 Diabetes Mellitus Patients with Iglarlixi: A Patient-Level Simulation Study

Authors: Ankita Chauhan, Mihail Samnaliev, Jennifer Ken-Opurum, Sesha Sai Srinivas Sistla, Aashay Mehta, Terry Dex, Scott Charland, Andrew Revel, Preblick R
Presenter: Jennifer Ken-Opurum
Date: Monday, May 8, 2023
Poster session time: 3:15 PM - 6:45 PM
Presentation time: 5:45 PM - 6:45 PM

 

Medtech Innovations in Oncology: A Review of NICE MedTech Innovation Briefings from 2014 to 2022

Authors: Jatinder Kumar, Pooja Gupta, Javed Shaikh, Mihail Samnaliev
Presenter: Ruihong Wang
Date: Tuesday, May 9, 2023
Poster session time: 9:45 AM - 1:15 PM
Presentation time: 12:15 PM - 1:15 PM

 

Targeted Literature Review of Economic Burden and Modelling Techniques for Duchenne Muscular Dystrophy

Authors: Mayank Vir, Tejaswinee Shah, Arpit Mittal, Ruihong Wang, Geetika Sharma, Javed Shaikh, Mihail Samnaliev
Presenter: Luke Schmerold
Date: Tuesday, May 9, 2023
Poster session time: 9:45 AM - 1:15 PM
Presentation time: 12:15 PM - 1:15 PM

 

Medical Technology Guidance: A Review to Identify the Evidence Gaps and Data Needs

Authors: Jatinder Kumar, Geetika Sharma, Divya Tamminina, Arpit Mittal, Abdul Shakira
Presenter: Ruihong Wang
Date: Tuesday, May 9, 2023
Poster session time: 3:15 PM - 6:45 PM
Presentation time: 3:15 PM - 4:00 PM

Discuss your business needs and challenges with us.

Want to know more about Axtria’s offerings in RWE & HEOR?

Please contact Won Chan Lee and Chet Baboor at connect@axtria.com.

Learn more about our work and thought leadership

Real-World Evidence For Label Expansion
Seeing The Whole Elephant: Integrated Advanced Data Analytics In Support Of RWE
The Economic Value Of Insulin Glargine 300 U/Ml (GLA-300) In People ≥18 Years Of Age With Type 2 Diabetes Mellitus